Results 221 to 230 of about 15,143,293 (401)

Cysteine Alkylation in Enzymes and Transcription Factors: A Therapeutic Strategy for Cancer. [PDF]

open access: yesCancers (Basel)
Andrés CMC   +5 more
europepmc   +1 more source

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

open access: yesMolecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi   +12 more
wiley   +1 more source

Crosslinking of transcription factor TFIIIA to ribosomal 5S RNA fromX.laevisbytrans-diamminedichloroplatinum (II)

open access: green, 1989
Florence Baudin   +4 more
openalex   +2 more sources

Bioengineering facets of the tumor microenvironment in 3D tumor models: insights into cellular, biophysical and biochemical interactions

open access: yesFEBS Open Bio, EarlyView.
The tumor microenvironment is a dynamic, multifaceted complex system of interdependent cellular, biochemical, and biophysical components. Three‐dimensional in vitro models of the tumor microenvironment enable a better understanding of these interactions and their impact on cancer progression and therapeutic resistance.
Salma T. Rafik   +3 more
wiley   +1 more source

The role of pioneering transcription factors, chromatin accessibility and epigenetic reprogramming in oncogenic viruses. [PDF]

open access: yesFront Microbiol
Kgatle M   +5 more
europepmc   +1 more source

Overlapping sites for constitutive and induced DNA binding factors involved in interferon-stimulated transcription. [PDF]

open access: bronze, 1989
Trevor Dale   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy